Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo + Yervoy
nivolumab + ipilimumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Patients with hepatocellular carcinoma previously treated with sorafenib.
LAMPGEN ANALYSIS
Why it matters
Introduced dual checkpoint blockade for this previously treated liver cancer population under accelerated approval.
What research teams should watch
Record prior sorafenib use and monitor liver function to distinguish immune toxicity from underlying disease.
PRIMARY RECORDS